Toggle Main Menu Toggle Search

ePrints

Small-molecule MDM2-p53 inhibitors: recent advances

Lookup NU author(s): Bian Zhang, Professor Bernard Golding, Dr Ian Hardcastle

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).


Abstract

Potent and selective small-molecule inhibitors of the p53-MDM2 interaction intended for the treatment of p53 wild-type tumors have been designed and optimized in a number of chemical series. This review details recent disclosures of compounds in advanced optimization and features key series that have given rise to clinical trial candidates. The structure–activity relationships for inhibitor classes are discussed with reference to x-ray structures, and common structural features are identified.


Publication metadata

Author(s): Zhang B, Golding BT, Hardcastle IR

Publication type: Review

Journal: Future Medicinal Chemistry

Year: 2015

Volume: 7

Issue: 5

Pages: 631-645

Acceptance date: 01/01/1900

Print publication date: 01/04/2015

ISSN (print): 1756-8919

ISSN (electronic): 1756-8927

URL: http://dx.doi.org/10.4155/fmc.15.13

DOI: 10.4155/fmc.15.13


Actions

    Link to this publication


Share